Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin

Psilocybin, a naturally occurring psychedelic compound, shows promise for treating depression, anxiety, obsessive-compulsive disorder, and addiction. A review of preliminary clinical trials and neurobiological mechanisms suggests that psilocybin may produce long-term positive effects by altering the neurofunctional anatomy underlying these disorders. The compound appears to 'reset' neurological connections, potentially offering a novel foundation for medical intervention in mental health. The analysis focuses on neuropharmacological data to explain how psilocybin achieves its therapeutic benefits.

Study at a glance

Abstract

This review presents a general background of psilocybin pharmacology and discusses its uses in treating various mental health disorders such as depression, anxiety, obsessive-compulsive disorder, and addiction. A summary of preliminary clinical trials utilizing psilocybin in each disorder is presented, along with an analysis of the neurobiological mechanisms that could explain the results. The purpose of this review is to collect and analyze neuropharmacological data and form an understanding of the possible mechanisms underlying psilocybin’s long-term positive effects in those suffering from various mental health disorders. Psilocybin may be a crucial tool in altering the neurofunctional anatomy that is the pathological core of various mental health disorders. A ‘reset’ of these neurological connections could be the basis of psilocybin treatment and may perhaps inspire a novel foundation of neurological medical intervention in mental health disorders.